Cite
HARVARD Citation
Thomsen, F. et al. (2019). Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study. Acta oncologica. pp. 110-118. [Online].